Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133669) titled 'Effect of different doses of esketamine on the prevention of visceral traction reaction and inflammatory response in repeat caesarean sections: a randomized, double-blind, controlled clinical study' on Sept. 30.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Guanyun people's hospital
Condition:
Visceral traction pain during cesarean section
Intervention:
Group E2:Esketamine 0.20 mg/kg, diluted with normal saline to 10 mL, administered via intravenous push at a constant rate over 2 minutes.
Group C:Normal saline 10 mL, administered via intravenous push at a constant rate over 2 minu...